{"id":29542,"date":"-0001-11-30T00:00:00","date_gmt":"-0001-11-29T22:18:44","guid":{"rendered":""},"modified":"-0001-11-30T00:00:00","modified_gmt":"-0001-11-29T21:00:00","slug":"igytas-imunodeficitinis-sindromas","status":"publish","type":"catalog_entry","link":"https:\/\/www.pasveik.lt\/lt\/irasas\/igytas-imunodeficitinis-sindromas\/","title":{"rendered":"\u012egytas imunodeficitinis sindromas"},"content":{"rendered":"<p style=\"text-align:justify\"><strong>\u012egytas<br \/>\nimunodeficitinis sindromas<\/strong><\/p>\n<p style=\"text-align:justify\"><strong><\/strong><\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">APIBR\u0116\u017dIMAS<\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">AIDS (angl. acquired<br \/>\nimmune deficiency syndrome, \u201e\u012fgytasis imuninio nepakankamumo (imunodeficito)<br \/>\nsindromas\u201c) \u2013 nei\u0161gydoma infekcin\u0117 liga, kuri\u0105 sukelia \u017emogaus imunodeficito<br \/>\nvirusas (\u017dIV) (angl. HIV &#8211; Human Immunodeficiency Virus). AIDS b\u016bdinga stipri<br \/>\nimunosupresija, lemianti indikacines ligas, antrinius navikus ir neurologinius<br \/>\npoky\u010dius.<\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\"><\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">EPIDEMIOLOGIJA<\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">JAV AIDS serga 900 000<br \/>\n\u017emoni\u0173, 500 000 \u017emoni\u0173 jau mir\u0117, vaikai sudaro 1% sergan\u010di\u0173j\u0173 AIDS. Iki AIDS<br \/>\n\u017dIV u\u017esikr\u0117t\u0119 asmenys i\u0161gyvena apie 10 met\u0173, atsiradus AIDS jie i\u0161gyvena tik 2<br \/>\n\u2013 3 metus. Afrikoje yra su \u017dIV ir AIDS susijusi socioekonomin\u0117 kriz\u0117, nes<br \/>\ndauguma sergan\u010di\u0173j\u0173 yra darbingo am\u017eiaus (25 \u2013 45 met\u0173) \u017emon\u0117s. <\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">2007-ais metais buvo<br \/>\napskai\u010diuota, kad yra 33,2 milijono \u017emoni\u0173, u\u017esikr\u0117tusi\u0173 \u017dIV virusu. D\u0117l viruso<br \/>\nsukelto \u012fgyto imunodeficito sindromo (AIDS), pasaulyje jau mir\u0117 apie 2,1<br \/>\nmilijono \u017emoni\u0173, \u012fskaitant 330 t\u016bkstan\u010di\u0173 vaik\u0173.<\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\"><\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">LIGOS PRIE\u017dASTYS IR EIGA<\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">\u017dIV \u2013 \u017emogaus<br \/>\nimunodeficito virusas, naikinantis \u017emogaus imuniteto l\u0105steles, saugan\u010dias<br \/>\norganizm\u0105 nuo bakterij\u0173, virus\u0173, grybeli\u0173, pirmuoni\u0173. Paskutin\u0117 ir sunkiausia<br \/>\n\u017dIV infekcijos stadija vadinama AIDS (angl. Acquired Immune Deficiency<br \/>\nSyndrome) \u2013 \u012fgytu imunodeficito sindromu. Yra \u017einomos dvi \u017emogaus imunodeficito<br \/>\nviruso atmainos \u2013 \u017dIV-1 ir \u017dIV-2. Pastarasis da\u017eniau sutinkamas vakar\u0173<br \/>\nAfrikoje, jo sukelto AIDS eiga b\u016bna ilgesn\u0117. AIDS susergama, kai pasiekiamas<br \/>\nkritinis limfocit\u0173 kiekis, taip baigiasi visos \u017dIV infekcijos.<\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">\u017dIV gyvuoja tik \u017emogaus<br \/>\norganizme, patek\u0119s \u012f or\u0105 jis beveik tuo pat metu \u017e\u016bva. Jis priskirtinas<br \/>\nvirusams, kurie kaupia genetin\u0119 informacij\u0105 tik RNR (ribonukleinin\u0117 r\u016bg\u0161tis),<br \/>\ntai neleid\u017eia jam savaranki\u0161kai daugintis. Tam, kad \u017dIV daugint\u0173si reikalinga<br \/>\nkieno nors DNR, \u012f kuri\u0105 jis \u012fleist\u0173 savo genetin\u0119 informacij\u0105. Taigi savo<br \/>\ndauginimuisi \u017dIV naudojasi tam tikromis m\u016bs\u0173 imunin\u0117s sistemos l\u0105stel\u0117mis.<\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">U\u017ekr\u0117sti kitus galima jau<br \/>\n1-3 par\u0105 nuo u\u017esikr\u0117timo (ir vis\u0105 gyvenim\u0105). \u017dIV u\u017esikre\u010diama:<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:36.0pt;line-height:115%\"=\"\">\u2022 lytini\u0173 santyki\u0173 metu;<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:36.0pt;line-height:115%\"=\"\">\u2022 per krauj\u0105 (pvz., \u0161virk\u0161\u010diant narkotikus \u012f ven\u0105,<br \/>\nmedicinini\u0173 invazini\u0173 proced\u016br\u0173 metu, perpilant u\u017ekr\u0117st\u0105 krauj\u0105, darant<br \/>\ntatuiruotes ir kt.);<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:36.0pt;line-height:115%\"=\"\">\u2022 u\u017esikr\u0117tusiai motinai perdavus virus\u0105 k\u016bdikiui<br \/>\nn\u0117\u0161tumo, gimdymo ar \u017eindymo metu.<\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">Did\u017eiausia viruso<br \/>\nkoncentracija yra \u0161iuose \u017emogaus organizmo skys\u010diuose: kraujyje, spermoje,<br \/>\nmak\u0161ties i\u0161skyrose; ma\u017eesn\u0117 &#8211; seil\u0117se, a\u0161arose, motinos piene.<\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\"><\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">KLINIKA<\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">U\u017esikr\u0117tus virusu su<br \/>\nlaiku organizmas praranda galimyb\u0119 reaguoti \u012f u\u017ekre\u010diamas ligas sukeltas<br \/>\nkasdienini\u0173 virus\u0173 ir bakterij\u0173. Po\u017eymiams atsiradus, \u017emogus ima itin da\u017enai ir<br \/>\nsunkiai sirgti oportunistin\u0117mis infekcijomis (infekcijos, kurias sukelia<br \/>\nnuolat, normaliai \u017emogaus k\u016bne esan\u010dios bakterijos, kurios sveikam \u017emogui<br \/>\nnesukelia lig\u0173). Mir\u0161tama nuo \u012fvairi\u0173 komplikacij\u0173 susijusi\u0173 su paprastomis<br \/>\nligomis, kaip gripas, plau\u010di\u0173 u\u017edegimas, nes \u017emogus tampa itin jautrus bet<br \/>\nkokiam u\u017ekratui. D\u0117l papildom\u0173 lig\u0173 kaip v\u0117\u017eys ir i\u0161sekimo, AIDS pacientai<br \/>\nneturi galimybi\u0173 save apsaugoti.<\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">Simptomai:<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:36.0pt;line-height:115%\"=\"\">\u2022 S\u0105nari\u0173 skausmas<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:36.0pt;line-height:115%\"=\"\">\u2022 Viduriavimas<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:36.0pt;line-height:115%\"=\"\">\u2022 Bendras silpnumas<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:36.0pt;line-height:115%\"=\"\">\u2022 Kar\u0161\u010diavimas<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:36.0pt;line-height:115%\"=\"\">\u2022 K\u016bno mas\u0117s ma\u017e\u0117jimas<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:36.0pt;line-height:115%\"=\"\">\u2022 Limfmazgi\u0173 padid\u0117jimas<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:36.0pt;line-height:115%\"=\"\">\u2022 Raumen\u0173 skausmas<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:36.0pt;line-height:115%\"=\"\">\u2022 Odos b\u0117rimas<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:36.0pt;line-height:115%\"=\"\">\u2022 Rykl\u0117s skausmas<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:36.0pt;line-height:115%\"=\"\">\u2022 Naktinis prakaitavimas<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:36.0pt;line-height:115%\"=\"\"><\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">DIAGNOSTIKA<\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">Periodas po u\u017esikr\u0117timo<br \/>\niki atsirandant \u017dIV antik\u016bn\u0173 kraujyje vadinamas \u201elango periodu\u201c. Tad nustatyti<br \/>\norganizme \u017dIV galima tik po 25 dien\u0173 &#8211; 3 m\u0117nesi\u0173 nuo u\u017esikr\u0117timo atliekant<br \/>\nspecialius kraujo tyrimus. Juos galima pasidaryti bet kurioje ligonin\u0117je ir<br \/>\nanonimi\u0161kai. Aptikus \u017dIV antik\u016bn\u0173 rezultatas vertinamas kaip teigiamas. Ta\u010diau<br \/>\ntai dar ne galutinis atsakas, kadangi gautasis patvirtinamas kitu testu.<\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\"><\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">GYDYMAS<\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">Preparatai, naudojami<br \/>\ngydyti \u017dIV infekcij\u0105, neu\u017emu\u0161a viruso, o tik blokuoja j\u012f, trukdydami \u017dIV<br \/>\ndaugintis, ma\u017eindami jo aktyvum\u0105. Tai padeda atsigaminti imunin\u0117ms l\u0105stel\u0117ms.<br \/>\nVienu metu vartojami treji ar ketveri vaistai vadinami itin aktyvia<br \/>\nantiretrovirusine terapija, toks gydymas padeda suma\u017einti virus\u0105 kraujyje iki<br \/>\nneapibr\u0117\u017eto kiekio. Atrasta daug vaist\u0173 veikian\u010di\u0173 \u012fvairias \u017dIV viruso<br \/>\ndauginimosi grandis.<\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\"><\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">PROFILAKTIKA<\/p>\n<p style=\"text-align: justify;\" margin-bottom:10.0pt;line-height:115%\"=\"\">Nesusirgti AIDS, vadinasi<br \/>\nneu\u017esikr\u0117sti \u017dIV:<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:45.0pt;line-height:115%\"=\"\">\u2022 saugus lytinis elgesys \u2013 vengti lytin\u0117s<br \/>\ndaugiapartneryst\u0117s, naudoti prezervatyv\u0105 viso lytinio akto metu<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:45.0pt;line-height:115%\"=\"\">\u2022 kraujo donor\u0173 tikrinimas d\u0117l \u017dIV<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:45.0pt;line-height:115%\"=\"\">\u2022 naudoti apsaugos priemones kontaktuojant su<br \/>\nkrauju<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:45.0pt;line-height:115%\"=\"\">\u2022 patikimas instrument\u0173 (pvz.: adat\u0173, \u0161virk\u0161t\u0173)<br \/>\nsterilizavimas<\/p>\n<p style=\"text-align: justify;\" margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:45.0pt;line-height:115%\"=\"\">\u2022 nevartoti narkotik\u0173 \u012f ven\u0105, o vartojant \u2013<br \/>\nnaudoti vienkartinius \u0161virk\u0161tus.<\/p>\n<div style=\"text-align:justify\"><\/div>\n","protected":false},"featured_media":0,"template":"","tags":[27926,27925],"catalog_supplier":[],"catalog":[27441],"class_list":["post-29542","catalog_entry","type-catalog_entry","status-publish","hentry","tag-aids","tag-igytas-imunodeficitinis-sindromas","catalog-infekcines-ligos"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/catalog_entry\/29542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/catalog_entry"}],"about":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/types\/catalog_entry"}],"wp:attachment":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/media?parent=29542"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/tags?post=29542"},{"taxonomy":"catalog_supplier","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/catalog_supplier?post=29542"},{"taxonomy":"catalog","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/catalog?post=29542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}